NHERF2 specifically interacts with LPA2 receptor and defines the specificity and efficiency of receptor-mediated phospholipase C-β3 activation

Molecular and Cellular Biology

Volumn 24, Issue 11, 2004, Pages 5069-5079

  Oh, Yong Seok ^a   Jo, Nam Won ^a   Choi, Jung Woong ^a   Kim, Hyeon Soo ^a   Seo, Sang Won ^a   Kang, Kyung Ok ^a   Hwang, Jong Ik ^a   Heo, Kyun ^a   Kim, Sun Hee ^a   Kim, Yun Hee ^a   Kim, In Hoo ^b   Kim, Jae Ho ^c   Banno, Yoshiko ^d   Ryu, Sung Ho ^a   Suh, Pann Ghill ^a  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

^b National Cancer Center   (South Korea)

^c Pusan National University School of Medicine   (South Korea)

^d GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYCLOOXYGENASE 2; G PROTEIN COUPLED RECEPTOR; LYSOPHOSPHATIDIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; NHERF2 PROTEIN; PHOSPHOLIPASE C; PHOSPHOLIPASE C BETA3; SODIUM PROTON EXCHANGE PROTEIN; SODIUM PROTON EXCHANGE PROTEIN REGULATORY FACTOR; UNCLASSIFIED DRUG;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CELL STRAIN COS7; CONTROLLED STUDY; ENZYME ACTIVATION; GENE MUTATION; GENE SILENCING; HELA CELL; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MAMMAL CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; VIRUS INFECTION; VIRUS RECOMBINANT;

ANIMALS; COS CELLS; CYCLOOXYGENASE 2; CYTOSKELETAL PROTEINS; HELA CELLS; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOLIPASE C; PHOSPHOPROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, LYSOPHOSPHATIDIC ACID; SODIUM-HYDROGEN ANTIPORTER; SUBSTRATE SPECIFICITY;

ADENOVIRIDAE; ANIMALIA; MAMMALIA;

EID: 2442676625     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.11.5069-5079.2004     Document Type: Article

References (47)

1. An, S., T. Bleu, O. G. Hallmark, and E. J. Goetzl. 1998. Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid. J. Biol. Chem. 273:7906-7910.
2. 1-adrenergic receptors to phospholipase C-β1 in rat neonatal cardiomyocytes. J. Biol. Chem. 276: 37341-37346.
3. Bandoh, K., J. Aoki, A. Taira, M. Tsujimoto, H. Arai, and K. Inoue. 2000. Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species: structure-activity relationship of cloned LPA receptors. FEBS Lett. 478:159-165.
4. Bandoh, K., J. Aoki, H. Hosono, S. Kobayashi, T. Kobayashi, K. Murakami-Murofushi, M. Tsujimoto, H. Arai, and K. Inoue. 1999. Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid. J. Biol. Chem. 274:27776-27785.
5. Beekman, A., B. Helfrich, P. A. Bunn, Jr., and L. E. Heasley. 1998. Expression of catalytically inactive phospholipase C-β disrupts phospholipase C-β and mitogen-activated protein kinase signaling and inhibits small cell lung cancer growth. Cancer Res. 58:910-913.
6. Bretscher, A., D. Chambers, R. Nguyen, and D. Reczek. 2000. ERM-Merlin and EBP50 protein families in plasma membrane organization and function. Annu. Rev. Cell Dev. Biol. 16:113-143.
7. + exchanger regulatory factor 2 mediates phosphorylation of serum- and glucocorticoid-induced protein kinase 1 by 3-phosphoinositide-dependent protein kinase 1. Biochem. Biophys. Res. Commun. 298:207-215.
8. Contos, J. J., I. Ishii, N. Fukushima, M. A. Kingsbury, X. Ye, S. Kawamura, J. H. Brown, and J. Chun. 2002. Characterization of lpa(2) (Edg4) and lpa(1)/lpa(2) (Edg2/Edg4) lysophosphatidic acid receptor knockout mice: signaling deficits without obvious phenotypic abnormality attributable to lpa(2). Mol. Cell. Biol. 22:6921-6929.
9. Contos, J. J., and J. Chun. 2000. Genomic characterization of the lysophosphatidic acid receptor gene, lp(A2)/Edg4, and identification of a frameshift mutation in a previously characterized cDNA. Genomics 64:155-169.
10. + exchanger regulatory factor 2 in apical plasma membranes. J. Biol. Chem. 277:10506-10511.
11. Erickson, J. R., Y. Hasegawa, X. Fang, A. Eder, M. Mao, T. Furui, J. Aoki, A. Morris, and G. B. Mills. 2001. Lysophosphatidic acid and ovarian cancer: a paradigm for tumorigenesis and patient management. Prostaglandins 64: 63-81.
12. Fang, X., S. Yu, J. L. Tanyi, Y. Lu, J. R. Woodgett, and G. B. Mills. 2002. Convergence of multiple signaling cascades at glycogen synthase kinase-3: Edg receptor-mediated phosphorylation and inactivation by lysophosphatidic acid through a protein kinase C-dependent intracellular pathway. Mol. Cell. Biol. 22:2099-2110.
13. Goetzl, E. J., H. Dolezalova, Y. Kong, Y. L. Hu, R. B. Jaffe, K. R. Kalli, and C. A. Conover. 1999. Distinctive expression and functions of the type 4 endothelial differentiation gene-encoded G protein-coupled receptor for lysophosphatidic acid in ovarian cancer. Cancer Res. 59:5370-5375.
14. 16 and phospholipase C-β2 by interacting with specific receptors in rat heart membranes. Cell. Signal 13:43-49.
15. Hall, R. A., and R. J. Lefkowitz. 2002. Regulation of G protein-coupled receptor signaling by scaffold proteins. Circ. Res. 91:672-680.
16. + exchanger regulatory factor family of PDZ proteins. Proc. Natl. Acad. Sci. USA 95:8496-8501.
17. + exchange. Nature 392: 626-630.
18. Hecht, J. H., J. A. Weiner, S. R. Post, and J. Chun. 1996. Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex. J. Cell Biol. 135:1071-1083.
19. Ho, S. N., H. D. Hunt, R. M. Horton, J. K. Pullen, and L. R. Pease. 1989. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51-59.
20. Hung, A. Y., and M. Sheng. 2002. PDZ domains: structural modules for protein complex assembly. J. Biol. Chem. 277:5699-5702.
21. + exchanger regulatory factor 2. J. Biol. Chem. 275:16632-16637.
22. Im, D. S., C. E. Heise, M. A. Harding, S. R. George, B. F. O'Dowd, D. Theodorescu, and K. R. Lynch. 2000. Molecular cloning and characterization of a lysophosphatidic acid receptor, Edg-7, expressed in prostate. Mol. Pharmacol. 57:753-759.
23. Ishii, I., J. J. Contos, N. Fukushima, and J. Chun. 2000. Functional comparisons of the lysophosphatidic acid receptors, LP(A1)/VZG-1/EDG-2, LP(A2)/EDG-4, and LP(A3)/EDG-7 in neuronal cell lines using a retrovirus expression system. Mol. Pharmacol. 58:895-902.
24. Kanai, F., P. A. Marignani, D. Sarbassova, R. Yagi, R. A. Hall, M. Donowitz, A. Hisaminato, T. Fujiwara, Y. Ito, L. C. Cantley, and M. B. Yaffe. 2000. TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins. EMBO J. 19:6778-6791.
25. src. J. Biol. Chem. 275:12619-12625.
26. Kim, D., K. S. Jun, S. B. Lee, N. G. Kang, D. S. Min, Y. H. Kim, S. H. Ryu, P. G. Suh, and H. S. Shin. 1997. Phospholipase C isozymes selectively couple to specific neurotransmitter receptors. Nature 389:290-293.
27. + exchanger 3 (NHE3) requires an NHE3-E3KARP-α-actinin-4 complex for oligomerization and endocytosis. J. Biol. Chem. 277:23714-23724.
28. Koki, A., N. K. Khan, B. M. Woerner, A. J. Dannenberg, L. Olson, K. Seibert, D. Edwards, M. Hardy, P. Isakson, and J. L. Masferrer. 2002. Cyclooxygenase-2 in human pathological disease. Adv. Exp. Med. Biol. 507:177-184.
29. Lamprecht, G., E. J. Weinman, and C. H. Yun. 1998. The role of NHERF and E3KARP in the cAMP-mediated inhibition of NHE3. J. Biol. Chem. 273:29972-29978.
30. Lau, A. G., and R. A. Hall. 2001. Oligomerization of NHERF-1 and NHERF-2 PDZ domains: differential regulation by association with receptor carboxyl termini and by phosphorylation. Biochemistry 40:8572-8580.
31. + exchanger regulatory factor 2 directs parathyroid hormone 1 receptor signalling. Nature 417:858-861.
32. Mattingly, R. R., V. Saini, and I. G. Macara. 1999. Activation of the Ras-GRF/CDC25Mm exchange factor by lysophosphatidic acid. Cell. Signal 11: 603-610.
33. + exchanger regulatory factor potentiates receptor activity. Mol. Cell. Biol. 20:8352-8363.
34. Moolenaar, W. H., O. Kranenburg, F. R. Postma, and G. C. Zondag. 1997. Lysophosphatidic acid: G-protein signalling and cellular responses. Curr. Opin. Cell Biol. 9:168-173.
35. Nebigil, C. G. 1997. Suppression of phospholipase C-β, -γ, and -δ families alters cell growth and phosphatidylinositol 4,5-bisphosphate levels. Biochemistry 36:15949-15958.
36. Pages, C., M. F. Simon, P. Valet, and J. S. Saulnier-Blache. 2001. Lysophosphatidic acid synthesis and release. Prostaglandins Other Lipid Mediat. 64:1-10.
37. Rhee, S. G. 2001. Regulation of phosphoinositide-specific phospholipase C. Annu. Rev. Biochem. 70:281-312.
38. Schulte, K. M., A. Beyer, K. Kohrer, S. Oberhauser, and H. D. Roher. 2001. Lysophosphatidic acid, a novel lipid growth factor for human thyroid cells: overexpression of the high-affinity receptor edg4 in differentiated thyroid cancer. Int. J. Cancer 92:249-256.
39. Sheng, H., C. S. Williams, J. Shao, P. Liang, R. N. DuBois, and R. D. Beauchamp. 1998. Induction of cyclooxygenase-2 by activated Ha-ras oncogene in Rat-1 fibroblasts and the role of mitogen-activated protein kinase pathway. J. Biol. Chem. 273:22120-22127.
40. Smrcka, A. V., and P. C. Sternweis. 1993. Regulation of purified subtypes of phosphatidylinositol-specific phospholipase C-β by G protein α and βγ subunits J. Biol. Chem. 268:9667-9674.
41. 2 purinergic and M3 muscarinic acetylcholine receptors activate different phospholipase C-β isoforms that are uniquely susceptible to protein kinase C-dependent phosphorylation and inactivation. J. Biol. Chem. 275:39767-39772.
42. Strassheim, D., P. Y. Law, and H. H. Loh. 1998. Contribution of phospholipase C-β3 phosphorylation to the rapid attenuation of opioid-activated phosphoinositide response. Mol. Pharmacol. 53:1047-1053.
43. Voltz, J. W., E. J. Weinman, and S. Shenolikar. 2001. Expanding the role of NHERF, a PDZ-domain containing protein adapter, to growth regulation. Oncogene 20:6309-6314.
44. Wang, S., R. W. Raab, P. J. Schatz, W. B. Guggino, and M. Li. 1998. Peptide binding consensus of the NHE-RF-PDZ1 domain matches the C-terminal sequence of cystic fibrosis transmembrane conductance regulator (CFFR). FEBS Lett. 427:103-108.
45. Weinman, E. J., C. Minkoff, and S. Shenolikar. 2000. Signal complex regulation of renal transport proteins: NHERF and regulation of NHE3 by PKA. Am. J. Physiol. Renal Physiol. 279:F393-F399.
46. Xu, Y., Z. Shen, D. W. Wiper, M. Wu, R. E. Morton, P. Elson, A. W. Kennedy, J. Belinson, M. Markman, and G. Casey. 1998. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. JAMA 280: 719-723.
47. + exchanger isoform 3 revisited: the roles of SGK1 and NHERF2. J. Biol. Chem. 277:7676-7683.